nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadopentetate dimeglumine—PGD—Pentose Phosphate Pathway—PGLS—osteoporosis	0.138	0.603	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—PKM—osteoporosis	0.00812	0.0354	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—PGLS—osteoporosis	0.0077	0.0336	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—TPI1—osteoporosis	0.00422	0.0184	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—GAPDH—osteoporosis	0.00389	0.017	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—AGER—osteoporosis	0.00318	0.0138	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—ENO1—osteoporosis	0.00307	0.0134	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PKM—osteoporosis	0.0023	0.01	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—SOST—osteoporosis	0.0023	0.01	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PGLS—osteoporosis	0.00218	0.00951	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—ANTXR2—osteoporosis	0.00218	0.00951	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PKM—osteoporosis	0.00193	0.0084	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—FDPS—osteoporosis	0.00193	0.0084	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—GSN—osteoporosis	0.00186	0.00808	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PGLS—osteoporosis	0.00183	0.00796	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GPD2—osteoporosis	0.00183	0.00796	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ATIC—osteoporosis	0.00167	0.00728	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PNP—osteoporosis	0.00167	0.00728	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—LRP5—osteoporosis	0.00161	0.00703	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—LRP6—osteoporosis	0.00154	0.00673	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RPL24—osteoporosis	0.00148	0.00646	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—LTF—osteoporosis	0.00148	0.00646	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CA2—osteoporosis	0.00142	0.00619	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—OXCT1—osteoporosis	0.00142	0.00619	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—MGLL—osteoporosis	0.00138	0.00603	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—TGFB1—osteoporosis	0.00134	0.00585	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—ACP5—osteoporosis	0.00129	0.0056	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—TPI1—osteoporosis	0.0012	0.00521	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—IDH2—osteoporosis	0.00118	0.00513	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—P4HB—osteoporosis	0.00112	0.0049	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CYP27A1—osteoporosis	0.00111	0.00482	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—GAPDH—osteoporosis	0.0011	0.00481	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ACP5—osteoporosis	0.00108	0.00469	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—NFATC1—osteoporosis	0.00105	0.00457	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—DKK1—osteoporosis	0.00104	0.00453	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—WNT1—osteoporosis	0.001	0.00436	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—TPI1—osteoporosis	0.001	0.00436	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—FGA—osteoporosis	0.000974	0.00425	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—P4HB—osteoporosis	0.000941	0.0041	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GAPDH—osteoporosis	0.000924	0.00403	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—RAP1A—osteoporosis	0.0009	0.00392	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—ENO1—osteoporosis	0.000869	0.00378	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PSMA2—osteoporosis	0.000856	0.00373	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PSMA5—osteoporosis	0.000856	0.00373	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CALCA—osteoporosis	0.000798	0.00348	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ENO1—osteoporosis	0.000727	0.00317	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—KL—osteoporosis	0.000724	0.00316	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PSMA5—osteoporosis	0.000717	0.00312	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PSMA2—osteoporosis	0.000717	0.00312	CbGpPWpGaD
Gadopentetate dimeglumine—Dermatitis—Etidronic acid—osteoporosis	0.00069	0.000895	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Pamidronate—osteoporosis	0.000688	0.000893	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Conjugated Estrogens—osteoporosis	0.000688	0.000892	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Zoledronate—osteoporosis	0.000687	0.000892	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Alendronate—osteoporosis	0.000687	0.000892	CcSEcCtD
Gadopentetate dimeglumine—Headache—Etidronic acid—osteoporosis	0.000686	0.00089	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000682	0.000885	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Estropipate—osteoporosis	0.000679	0.000882	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Estradiol—osteoporosis	0.000679	0.000882	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Pamidronate—osteoporosis	0.000678	0.00088	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Zoledronate—osteoporosis	0.000678	0.00088	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Zoledronate—osteoporosis	0.000678	0.00088	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Zoledronate—osteoporosis	0.000676	0.000877	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000674	0.000875	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000673	0.000874	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Risedronate—osteoporosis	0.000672	0.000872	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Estropipate—osteoporosis	0.00067	0.00087	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Alendronate—osteoporosis	0.000669	0.000869	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Ibandronate—osteoporosis	0.000669	0.000868	CcSEcCtD
Gadopentetate dimeglumine—Cough—Conjugated Estrogens—osteoporosis	0.000669	0.000868	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Risedronate—osteoporosis	0.000667	0.000866	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Estradiol—osteoporosis	0.000666	0.000865	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Pamidronate—osteoporosis	0.000665	0.000863	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Conjugated Estrogens—osteoporosis	0.000664	0.000862	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Zoledronate—osteoporosis	0.000663	0.00086	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000663	0.00086	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000662	0.000859	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Alendronate—osteoporosis	0.00066	0.000856	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Estradiol—osteoporosis	0.000659	0.000855	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Estradiol—osteoporosis	0.000657	0.000853	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Ethinyl Estradiol—osteoporosis	0.000656	0.000852	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Zoledronate—osteoporosis	0.000655	0.00085	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Calcitriol—osteoporosis	0.000655	0.00085	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Estradiol—osteoporosis	0.000654	0.000849	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Estradiol—osteoporosis	0.000654	0.000849	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Conjugated Estrogens—osteoporosis	0.000653	0.000847	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Conjugated Estrogens—osteoporosis	0.000653	0.000847	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Ibandronate—osteoporosis	0.000652	0.000846	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Conjugated Estrogens—osteoporosis	0.00065	0.000844	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Etidronic acid—osteoporosis	0.00065	0.000844	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Zoledronate—osteoporosis	0.00065	0.000843	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000648	0.000841	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000648	0.000841	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Estropipate—osteoporosis	0.000648	0.000841	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000646	0.000839	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Risedronate—osteoporosis	0.000645	0.000837	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Ibandronate—osteoporosis	0.000642	0.000834	CcSEcCtD
Gadopentetate dimeglumine—Pain—Risedronate—osteoporosis	0.00064	0.000831	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Risedronate—osteoporosis	0.00064	0.000831	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Estradiol—osteoporosis	0.00064	0.00083	CcSEcCtD
Gadopentetate dimeglumine—Shock—Zoledronate—osteoporosis	0.000639	0.00083	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Pamidronate—osteoporosis	0.000639	0.000829	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Alendronate—osteoporosis	0.000638	0.000828	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Calcitriol—osteoporosis	0.000638	0.000828	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Zoledronate—osteoporosis	0.000637	0.000827	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Estradiol—osteoporosis	0.000637	0.000826	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Estradiol—osteoporosis	0.000635	0.000825	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Pamidronate—osteoporosis	0.000634	0.000823	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Zoledronate—osteoporosis	0.000634	0.000823	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000633	0.000821	CcSEcCtD
Gadopentetate dimeglumine—Chills—Estradiol—osteoporosis	0.000632	0.000821	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Pamidronate—osteoporosis	0.000632	0.000821	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Zoledronate—osteoporosis	0.000631	0.000819	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Calcitriol—osteoporosis	0.000629	0.000816	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Zoledronate—osteoporosis	0.000628	0.000815	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000628	0.000815	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Raloxifene—osteoporosis	0.000628	0.000815	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Estropipate—osteoporosis	0.000626	0.000813	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000626	0.000812	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Ibandronate—osteoporosis	0.000621	0.000806	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Zoledronate—osteoporosis	0.000619	0.000804	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Pamidronate—osteoporosis	0.000618	0.000803	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Estradiol—osteoporosis	0.000618	0.000801	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Alendronate—osteoporosis	0.000617	0.000801	CcSEcCtD
Gadopentetate dimeglumine—Shock—Conjugated Estrogens—osteoporosis	0.000616	0.000799	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000614	0.000797	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000614	0.000796	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Estradiol—osteoporosis	0.000614	0.000796	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Pamidronate—osteoporosis	0.000613	0.000796	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Risedronate—osteoporosis	0.000612	0.000794	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000611	0.000793	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Ethinyl Estradiol—osteoporosis	0.00061	0.000791	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Pamidronate—osteoporosis	0.000608	0.00079	CcSEcCtD
Gadopentetate dimeglumine—Pain—Pamidronate—osteoporosis	0.000608	0.00079	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Calcitriol—osteoporosis	0.000608	0.000789	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000608	0.000789	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Zoledronate—osteoporosis	0.000607	0.000788	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000607	0.000788	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000607	0.000788	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Raloxifene—osteoporosis	0.000607	0.000787	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000605	0.000785	CcSEcCtD
Gadopentetate dimeglumine—Tension—Estradiol—osteoporosis	0.000602	0.000782	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Estropipate—osteoporosis	0.000602	0.000781	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Estradiol—osteoporosis	0.000601	0.00078	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Ibandronate—osteoporosis	0.000601	0.000779	CcSEcCtD
Gadopentetate dimeglumine—Rash—Estropipate—osteoporosis	0.000597	0.000775	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Estropipate—osteoporosis	0.000597	0.000774	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Conjugated Estrogens—osteoporosis	0.000596	0.000774	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Risedronate—osteoporosis	0.000595	0.000772	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Estradiol—osteoporosis	0.000594	0.00077	CcSEcCtD
Gadopentetate dimeglumine—Headache—Estropipate—osteoporosis	0.000593	0.00077	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Alendronate—osteoporosis	0.000593	0.00077	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000592	0.000768	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Risedronate—osteoporosis	0.000592	0.000768	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Risedronate—osteoporosis	0.000592	0.000768	CcSEcCtD
Gadopentetate dimeglumine—Rash—Alendronate—osteoporosis	0.000588	0.000763	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Alendronate—osteoporosis	0.000588	0.000763	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Pamidronate—osteoporosis	0.000586	0.000761	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Conjugated Estrogens—osteoporosis	0.000585	0.000759	CcSEcCtD
Gadopentetate dimeglumine—Headache—Alendronate—osteoporosis	0.000584	0.000758	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Zoledronate—osteoporosis	0.000584	0.000757	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Raloxifene—osteoporosis	0.000583	0.000757	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000582	0.000755	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—CYP19A1—osteoporosis	0.000582	0.00253	CbGpPWpGaD
Gadopentetate dimeglumine—Dyspnoea—Zoledronate—osteoporosis	0.000579	0.000752	CcSEcCtD
Gadopentetate dimeglumine—Rash—Raloxifene—osteoporosis	0.000578	0.000751	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Raloxifene—osteoporosis	0.000578	0.00075	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Zoledronate—osteoporosis	0.000578	0.00075	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Ibandronate—osteoporosis	0.000577	0.000749	CcSEcCtD
Gadopentetate dimeglumine—Tremor—Estradiol—osteoporosis	0.000575	0.000746	CcSEcCtD
Gadopentetate dimeglumine—Headache—Raloxifene—osteoporosis	0.000575	0.000746	CcSEcCtD
Gadopentetate dimeglumine—Rash—Ibandronate—osteoporosis	0.000573	0.000743	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Ibandronate—osteoporosis	0.000572	0.000742	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00057	0.00074	CcSEcCtD
Gadopentetate dimeglumine—Headache—Ibandronate—osteoporosis	0.000569	0.000738	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—ADCY5—osteoporosis	0.000567	0.00247	CbGpPWpGaD
Gadopentetate dimeglumine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000566	0.000734	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Calcitriol—osteoporosis	0.000565	0.000734	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Zoledronate—osteoporosis	0.000565	0.000733	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Estradiol—osteoporosis	0.000564	0.000732	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Estropipate—osteoporosis	0.000563	0.00073	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Pamidronate—osteoporosis	0.000562	0.00073	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Pamidronate—osteoporosis	0.000562	0.00073	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000562	0.000729	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000561	0.000728	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Estradiol—osteoporosis	0.000561	0.000728	CcSEcCtD
Gadopentetate dimeglumine—Rash—Calcitriol—osteoporosis	0.000561	0.000727	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Zoledronate—osteoporosis	0.00056	0.000727	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Calcitriol—osteoporosis	0.00056	0.000727	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000558	0.000724	CcSEcCtD
Gadopentetate dimeglumine—Headache—Calcitriol—osteoporosis	0.000557	0.000723	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Conjugated Estrogens—osteoporosis	0.000556	0.000722	CcSEcCtD
Gadopentetate dimeglumine—Pain—Zoledronate—osteoporosis	0.000556	0.000721	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Zoledronate—osteoporosis	0.000556	0.000721	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Alendronate—osteoporosis	0.000554	0.000719	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Estradiol—osteoporosis	0.000553	0.000718	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Risedronate—osteoporosis	0.000551	0.000716	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000551	0.000715	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Estradiol—osteoporosis	0.00055	0.000714	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Raloxifene—osteoporosis	0.000545	0.000707	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000544	0.000706	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000543	0.000705	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00054	0.000701	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Conjugated Estrogens—osteoporosis	0.000539	0.0007	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Ibandronate—osteoporosis	0.000539	0.0007	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Estradiol—osteoporosis	0.000539	0.0007	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Risedronate—osteoporosis	0.000537	0.000697	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Zoledronate—osteoporosis	0.000536	0.000695	CcSEcCtD
Gadopentetate dimeglumine—Cough—Estradiol—osteoporosis	0.000535	0.000695	CcSEcCtD
Gadopentetate dimeglumine—Pain—Conjugated Estrogens—osteoporosis	0.000535	0.000694	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Conjugated Estrogens—osteoporosis	0.000535	0.000694	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000531	0.00069	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Estradiol—osteoporosis	0.00053	0.000688	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Risedronate—osteoporosis	0.000529	0.000687	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Calcitriol—osteoporosis	0.000528	0.000685	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000525	0.000682	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Pamidronate—osteoporosis	0.000524	0.00068	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Estradiol—osteoporosis	0.000522	0.000678	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Estradiol—osteoporosis	0.000522	0.000678	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—MTHFR—osteoporosis	0.000522	0.00227	CbGpPWpGaD
Gadopentetate dimeglumine—Anxiety—Estradiol—osteoporosis	0.000521	0.000676	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000519	0.000673	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Zoledronate—osteoporosis	0.000516	0.00067	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Zoledronate—osteoporosis	0.000514	0.000667	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Zoledronate—osteoporosis	0.000514	0.000667	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Risedronate—osteoporosis	0.000512	0.000665	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000512	0.000664	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Estradiol—osteoporosis	0.000511	0.000663	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Pamidronate—osteoporosis	0.00051	0.000662	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000508	0.000659	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Estradiol—osteoporosis	0.000505	0.000655	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Pamidronate—osteoporosis	0.000503	0.000653	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Estradiol—osteoporosis	0.000501	0.00065	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Conjugated Estrogens—osteoporosis	0.000497	0.000645	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—IRS2—osteoporosis	0.000496	0.00216	CbGpPWpGaD
Gadopentetate dimeglumine—Dizziness—Risedronate—osteoporosis	0.000495	0.000642	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000495	0.000642	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000495	0.000642	CcSEcCtD
Gadopentetate dimeglumine—Shock—Estradiol—osteoporosis	0.000493	0.000639	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Estradiol—osteoporosis	0.000491	0.000637	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Estradiol—osteoporosis	0.000489	0.000634	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000488	0.000633	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Pamidronate—osteoporosis	0.000487	0.000632	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Estradiol—osteoporosis	0.000486	0.000631	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Estradiol—osteoporosis	0.000484	0.000628	CcSEcCtD
Gadopentetate dimeglumine—Rash—Ethinyl Estradiol—osteoporosis	0.000484	0.000628	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000484	0.000628	CcSEcCtD
Gadopentetate dimeglumine—Headache—Ethinyl Estradiol—osteoporosis	0.000481	0.000624	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Zoledronate—osteoporosis	0.000479	0.000621	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Risedronate—osteoporosis	0.000476	0.000618	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—ADCY5—osteoporosis	0.000475	0.00207	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GPX1—osteoporosis	0.000474	0.00206	CbGpPWpGaD
Gadopentetate dimeglumine—Rash—Risedronate—osteoporosis	0.000472	0.000612	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Risedronate—osteoporosis	0.000471	0.000612	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Pamidronate—osteoporosis	0.00047	0.000611	CcSEcCtD
Gadopentetate dimeglumine—Headache—Risedronate—osteoporosis	0.000469	0.000608	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Zoledronate—osteoporosis	0.000466	0.000605	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000461	0.000598	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Zoledronate—osteoporosis	0.00046	0.000597	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000456	0.000592	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Ethinyl Estradiol—osteoporosis	0.000456	0.000592	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Pamidronate—osteoporosis	0.000452	0.000587	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Estradiol—osteoporosis	0.00045	0.000584	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Conjugated Estrogens—osteoporosis	0.000449	0.000583	CcSEcCtD
Gadopentetate dimeglumine—Rash—Pamidronate—osteoporosis	0.000449	0.000582	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Pamidronate—osteoporosis	0.000448	0.000582	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Estradiol—osteoporosis	0.000446	0.000579	CcSEcCtD
Gadopentetate dimeglumine—Headache—Pamidronate—osteoporosis	0.000446	0.000578	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Estradiol—osteoporosis	0.000445	0.000578	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Zoledronate—osteoporosis	0.000445	0.000577	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Risedronate—osteoporosis	0.000445	0.000577	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Conjugated Estrogens—osteoporosis	0.000443	0.000575	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—MTHFR—osteoporosis	0.000437	0.0019	CbGpPWpGaD
Gadopentetate dimeglumine—Decreased appetite—Estradiol—osteoporosis	0.000435	0.000565	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—IRS1—osteoporosis	0.000433	0.00189	CbGpPWpGaD
Gadopentetate dimeglumine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000432	0.000561	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Estradiol—osteoporosis	0.000432	0.00056	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Zoledronate—osteoporosis	0.00043	0.000558	CcSEcCtD
Gadopentetate dimeglumine—Pain—Estradiol—osteoporosis	0.000428	0.000556	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Estradiol—osteoporosis	0.000428	0.000556	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000428	0.000556	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Pamidronate—osteoporosis	0.000423	0.000548	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Conjugated Estrogens—osteoporosis	0.000414	0.000537	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Zoledronate—osteoporosis	0.000413	0.000536	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Estradiol—osteoporosis	0.000413	0.000536	CcSEcCtD
Gadopentetate dimeglumine—Rash—Zoledronate—osteoporosis	0.00041	0.000532	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Estradiol—osteoporosis	0.00041	0.000531	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Zoledronate—osteoporosis	0.000409	0.000531	CcSEcCtD
Gadopentetate dimeglumine—Headache—Zoledronate—osteoporosis	0.000407	0.000528	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—IL6R—osteoporosis	0.000407	0.00177	CbGpPWpGaD
Gadopentetate dimeglumine—Vomiting—Conjugated Estrogens—osteoporosis	0.000398	0.000516	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Estradiol—osteoporosis	0.000398	0.000516	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Estradiol—osteoporosis	0.000396	0.000514	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Estradiol—osteoporosis	0.000396	0.000514	CcSEcCtD
Gadopentetate dimeglumine—Rash—Conjugated Estrogens—osteoporosis	0.000395	0.000512	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000394	0.000512	CcSEcCtD
Gadopentetate dimeglumine—Headache—Conjugated Estrogens—osteoporosis	0.000392	0.000509	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Zoledronate—osteoporosis	0.000386	0.000501	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Conjugated Estrogens—osteoporosis	0.000372	0.000482	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Estradiol—osteoporosis	0.000369	0.000479	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Estradiol—osteoporosis	0.000359	0.000466	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Estradiol—osteoporosis	0.000354	0.00046	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—POMC—osteoporosis	0.000349	0.00152	CbGpPWpGaD
Gadopentetate dimeglumine—Diarrhoea—Estradiol—osteoporosis	0.000343	0.000445	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Estradiol—osteoporosis	0.000331	0.00043	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Estradiol—osteoporosis	0.000318	0.000413	CcSEcCtD
Gadopentetate dimeglumine—Rash—Estradiol—osteoporosis	0.000316	0.00041	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Estradiol—osteoporosis	0.000315	0.000409	CcSEcCtD
Gadopentetate dimeglumine—Headache—Estradiol—osteoporosis	0.000314	0.000407	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Estradiol—osteoporosis	0.000297	0.000386	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—MYC—osteoporosis	0.000241	0.00105	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—TGFB1—osteoporosis	0.000241	0.00105	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—IL6—osteoporosis	0.000181	0.00079	CbGpPWpGaD
